Fund HoldingsBirchview Capital, LP

Total Portfolio Value
$117.71M
Total Bought
$7.81M
Total Sold
$10.70M
Net Transaction
-$2.89M
Filing Period:
Securities
SharesValue ($K)
Q2 2023
Q3 2023
Change
Q2 2023
Q3 2023
Weight (%)
Change
BIODESIX INC5,039,6335,348,273+308,6406,1998,7417.43%+2,542
OVINTIV INC(OVV)84,20084,20003,2054,0053.40%+800
NEUROCRINE BIOSCIENCES INC(NBIX)84,24077,240-7,0007,9448,6907.38%+746
BLUEBIRD BIO INC249,200455,200+206,0008201,3841.18%+564
AXOGEN INC(AXGN)40,000173,000+133,0003658650.73%+500
PROGYNY INC9,00018,000+9,0003546120.52%+258
CORCEPT THERAPEUTICS INC(CORT)50,00050,00001,1131,3621.16%+250
KARYOPHARM THERAPEUTICS INC291,332571,832+280,5005217660.65%+245
10X GENOMICS INC(TXG)12,00021,000+9,0006708660.74%+196
TRAVERE THERAPEUTICS INC(TVTX)40,00082,000+42,0006147330.62%+119
KINIKSA PHARMACEUTICALS LTD30,00030,00004225210.44%+99
PIONEER NATURAL RESOURCES CO3,8003,80007878720.74%+85
G1 THERAPEUTICS INC40,000120,000+80,0001001730.15%+73
GOSSAMER BIO INC99,088209,088+110,0001191740.15%+55
VENTYX BIOSCIENCES INC26,40026,40008669170.78%+51
KALVISTA PHARMACEUTICALS INC40,00040,00003603850.33%+25
HALOZYME THERAPEUTICS INC(HALO)10,00010,00003613820.32%+21
SAREPTA THERAPEUTICS INC(SRPT)2,5002,50002863030.26%+17
BIOCRYST PHARMACEUTICALS INC(BCRX)20,00020,00001411420.12%+1
NEKTAR THERAPEUTICS(NKTR)28,00028,000016170.01%+1
AMICUS THERAPEUTICS INC
COM
28,00028,00003523400.29%-11
EQUITRANS MIDSTREAM CORPORATIO133,050133,05001,2721,2471.06%-25
SILK ROAD MEDICAL INC20,00041,294+21,2946506190.53%-31
YIELD10 BIOSCIENCE INC18,75018,75004260.01%-35
CULLINAN ONCOLOGY INC(CGEM)25,11425,11402702270.19%-43
XENON PHARMACEUTICALS INC(XENE)10,00010,00003853420.29%-43
KEROS THERAPEUTICS INC7,0007,00002812230.19%-58
XENCOR INC(XNCR)12,30012,30003072480.21%-59
INFLARX NV50,00050,00002231490.13%-74
ARVINAS INC15,00015,00003722950.25%-78
CYTOKINETICS INC(CYTK)25,00025,00008167370.63%-79
ALKERMES PLC(ALKS)50,00050,00001,5651,4011.19%-164
DOCGO INC110,000130,000+20,0001,0316930.59%-338
2SEVENTY BIO INC59,83359,83306062350.20%-371
ALPHATEC HOLDINGS INC(ATEC)80,00080,00001,4381,0380.88%-401
APELLIS PHARMACEUTICALS INC
COM
12,00018,000+6,0001,0936850.58%-408
PROTAGONIST THERAPEUTICS INC38,00038,00001,0506340.54%-416
ACCELERATE DIAGNOSTICS INC2,252,388225,239-2,027,1491,8241,2951.10%-529
INHIBRX INC70,44870,44801,8291,2931.10%-536
FOGHORN THERAPEUTICS INC264,843264,84301,8641,3241.12%-540
STOKE THERAPEUTICS INC(STOK)85,00085,00009043350.28%-569
IMMUNOGEN INC190,000190,00003,5853,0152.56%-570
CHINOOK THERAPEUTICS INC15,0000-15,0005760-576
QUIDELORTHO CORP65,20365,20305,4034,7624.05%-640
HARROW HEALTH INC(HROW)150,000150,00002,8562,1561.83%-700
UNITED THERAPEUTICS CORP(UTHR)15,00011,000-4,0003,3112,4852.11%-827
ACADIA PHARMACEUTICALS INC249,400240,400-9,0005,9735,0104.26%-963
IVERIC BIO INC25,0000-25,0009840-983
PHREESIA INC82,70082,70002,5651,5451.31%-1,020
SOLENO THERAPEUTICS INC245,1270-245,1271,0520-1,052
MASIMO CORP15,28015,28002,5141,3401.14%-1,175
ELUTIA INC1,655,1841,655,18403,9062,3672.01%-1,539
PROTHENA CORP PLC
SHS
156,111169,574+13,46310,6598,1826.95%-2,477
BRISTOL-MYERS SQUIBB CO(BMY)728,585716,297-12,28846,59341,57435.32%-5,019
Page 1 of 1